Synthesis, structure and affinity of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones for CNS central and peripheral benzodiazepine receptors

被引:9
作者
Andronati, Sergey [1 ]
Semenishyna, Ekaterina [1 ]
Pavlovsky, Victor [1 ]
Simonov, Yuriy [2 ]
Makan, Svetlana [1 ]
Boyko, Irina [1 ]
Burenkova, Natalya [1 ]
Gdaniec, Maria [3 ]
Cardinael, Pascal [4 ]
Bouillon, Jean-Philippe [4 ]
Mazepa, Alexander [1 ]
机构
[1] Natl Acad Sci Ukraine, AV Bogatsky Physicochem Inst, UA-65080 Odessa, Ukraine
[2] Moldavian Acad Sci, Inst Appl Phys, Kishinev, Moldova
[3] A Mitzkevitch Univ, Dept Chem, PL-60780 Poznan, Poland
[4] Univ Rouen, Sci & Methodes Separat EA 3233, IRCOF, F-76821 Mont St Aignan, France
关键词
3-alkoxy-1,2-dihydro-3H-1,4-bezodiazepin-2-ones; Enantiomer; Central benzodiazepine receptor; Peripheral benzodiazepine receptor; Affinity; X-ray analysis; GABA(A) RECEPTOR; PHARMACOLOGY; BINDING; ENANTIOMERS; LORAZEPAM; DIAZEPAM; OXAZEPAM; SUBTYPES; CRYSTAL; COMPLEX;
D O I
10.1016/j.ejmech.2009.12.027
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones (7-15) was synthesized and their in vitro affinity for both the central benzodiazepine receptor (CBR) and the peripheral benzodiazepine receptor (PBR) of rat brain was studied. Racemic mixture of 7-bromo-3-(2-methoxy)ethoxy-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepin-2-one (13) was separated into enantiomers 14, 15 by chiral HPLC. Absolute configuration of R-enantiomer 15 was determined by the method of X-ray diffraction analysis. The affinity of S-enantiomer 14 for CBR (IC50 = 245 nM) is 20-fold higher than the affinity of R-enantiomer 15 (IC50 = 4930 nM). A high selectivity for CBR versus PBR (IC50 (PBR) > 10000 nM) was shown by all reported compounds. Compound 12 was revealed as a potent (IC50 = 9 nM) and selective CBR ligand among the synthesized 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1346 / 1351
页数:6
相关论文
共 40 条
[1]   EFFECTS OF LORMETAZEPAM AND OF FLURAZEPAM ON SLEEP [J].
ADAM, K ;
OSWALD, I .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (05) :531-538
[2]  
ANDRONATI KS, 2003, Patent No. 60361
[3]  
ANSSEAU M, 1991, NEUROPSYCHOBIOLOGY, V24, P74
[4]   MACROCYCLIC ANTIBIOTICS AS A NEW CLASS OF CHIRAL SELECTORS FOR LIQUID-CHROMATOGRAPHY [J].
ARMSTRONG, DW ;
TANG, YB ;
CHEN, SS ;
ZHOU, YW ;
BAGWILL, C ;
CHEN, JR .
ANALYTICAL CHEMISTRY, 1994, 66 (09) :1473-1484
[5]   STUDIES IN DEPRESSION .6. OXAZEPAM IN THE TREATMENT OF ANXIETY ASSOCIATED WITH DEPRESSION - RESULTS OF TREATMENT IN 1600 CASES [J].
BAILEY, HR ;
DAVIES, E ;
MORRISON, IJ .
CURRENT MEDICAL RESEARCH AND OPINION, 1981, 7 (03) :156-163
[6]   CRYSTAL, MOLECULAR, AND ELECTRONIC-STRUCTURE OF AN ANTI-ANXIETY AGENT 7-CHLORO-5-(2-CHLOROPHENYL)-1,3-DIHYDRO-3-HYDROXY-1,4-BENZODIAZEPIN-2-ONE [J].
BANDOLI, G ;
CLEMENTE, DA .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1976, (04) :413-418
[7]  
Barnard EA, 1998, PHARMACOL REV, V50, P291
[8]  
BLASCHKE G, 1986, ARZNEIMITTELFORSCH, V36-1, P893
[9]   SPECIFIC BENZODIAZEPINE RECEPTORS IN RAT-BRAIN CHARACTERIZED BY HIGH-AFFINITY [DIAZEPAM-H-3] BINDING - (AFFINITY BINDING DIAZEPAM ANXIOLYTIC ACTIVITY BRAIN MEMBRANES REGIONAL DISTRIBUTION) [J].
BRAESTRUP, C ;
SQUIRES, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) :3805-3809
[10]  
Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO